Skip to main content
. Author manuscript; available in PMC: 2007 Feb 9.
Published in final edited form as: J Neuroimmunol. 2006 Dec 6;182(1-2):226–231. doi: 10.1016/j.jneuroim.2006.10.019

Table 3.

Cellular composition in BM

Genotype CD4% CD8% CD11b% CD45R% Ter119%
Young ALS2+/+ 1.6 ± 0.1 1.3 ± 0.2 46.9 ± 4.2 19.7 ± 4.6 20.1 ± 3.2
Young ALS2−/− 1.4 ± 0.1 1.1 ± 0.2 37.4 ± 4.6 18.9 ± 5.1 29.4 ± 3.5
Old ALS2+/+ 1.9 ± 0.2 1.4 ± 0.3 41.1 ± 5.1 24.0 ± 5.7 25.6 ± 3.9
Old ALS2−/− 2.9 ± 0.2 1.2 ± 0.3 37.7 ± 5.1 20.2 ± 5.7 36.6 ± 3.9
Statistics A, g, A*G NS NS NS g

BM cells from young (3 months) and old (14 months) ALS2 wild type (ALS2+/+) and ALS2 knockout (ALS2−/−) mice were analyzed by flow cytometry. Data shown are least square means ± standard errors of 6 mice from each of the two young groups and 4 mice from each of the two old groups after variance analyses. Statistic significance: A: significant age effect (P<0.01); g: significant genotype effect (P<0.05); A*G: significant age*genotype interaction (P<0.05); NS: no significance.